TrialEuropean journal of neurology2020

Efficacy of galcanezumab in patients with episodic migraine and a history of preventive treatment failure: results from two global randomized clinical trials.

D D Ruff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.